Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
Aiello TF, Puerta-Alcalde P, Chumbita M, Lopera C, Monzó P, Cortes A, Fernández-Avilés F, Suárez-Lledó M, Correa J, Ortiz-Maldonado V, Cuesta G, Martinez-Cibrian N, Esteve J, Marcos MÁ, Mensa J, Soriano A, Garcia-Vidal C. Aiello TF, et al. Among authors: esteve j. J Antimicrob Chemother. 2023 Jun 1;78(6):1454-1459. doi: 10.1093/jac/dkad105. J Antimicrob Chemother. 2023. PMID: 37051877 Free article.
Real-Life Comparison of Antivirals for SARS-CoV-2 Omicron Infection in Patients With Hematologic Malignancies.
Aiello TF, Peyrony O, Chumbita M, Monzó P, Lopera C, Puerta-Alcalde P, Magnano L, Fernández-Avilés F, Cuesta G, Tuset M, Mensa J, Esteve J, Marcos MA, Soriano A, Garcia-Vidal C. Aiello TF, et al. Among authors: esteve j. Influenza Other Respir Viruses. 2024;18(3):e13264. doi: 10.1111/irv.13264. Influenza Other Respir Viruses. 2024. PMID: 38468434 Free PMC article.
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.
Álamo JR, Torres LM, Castaño-Díez S, Mensa-Vilaró A, Mónica López-Guerra M, Zugasti I, Díaz J, Jiménez-Vicente C, Plaza S, Fabregat V, de Landazuri IO, Yagüe J, Espinosa G, Sanmartí R, Rozman M, Guijarro F, Cortes A, Triguero A, Cardús A, Cuartas A, Cornejo M, Esteve J, Aróstegui JI, Díaz-Beyá M. Álamo JR, et al. Among authors: esteve j. Br J Haematol. 2025 Jan 13. doi: 10.1111/bjh.19953. Online ahead of print. Br J Haematol. 2025. PMID: 39806534
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Oñate G, Garrido A, Arnan M, Pomares H, Alonso E, Tormo M, Diaz-Beya M, Vives S, Zamora L, Sampol A, Coll R, Salamero O, Cervera M, Garcia A, Vall-Llovera F, Garcia-Avila S, Bargay J, Ortin X, Iranzo E, Guijarro F, Pratcorona M, Nomdedeu JF, Esteve J, Sierra J. Oñate G, et al. Among authors: esteve j. Blood Cancer J. 2025 Jan 11;15(1):4. doi: 10.1038/s41408-024-01205-5. Blood Cancer J. 2025. PMID: 39799145 Free PMC article.
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.
Martínez-Roca A, Jiménez-Vicente C, Merchán B, Castaño-Diez S, Zugasti I, Brillembourg H, Bataller Á, Guijarro F, Cortés-Bullich A, Trigueros A, Pérez-Valencia AI, Gallego C, Ballestar N, Rodríguez-Lobato LG, Carcelero E, Díaz-Beyá M, Esteve J, Fernández-Avilés F. Martínez-Roca A, et al. Among authors: esteve j. Cancers (Basel). 2024 Dec 23;16(24):4274. doi: 10.3390/cancers16244274. Cancers (Basel). 2024. PMID: 39766173 Free PMC article.
Optimized GVHD Prevention in HLA-Mismatched Unrelated Allogeneic HCT Using a PTCY-Based Approach.
Pinto FR, Suárez-Lledó M, Guardia L, Charry P, Cid J, Lozano M, Pedraza A, de Llobet N, Corrius G, Moreno C, Esteve J, Serra C, Carreras E, Rosiñol L, Fernández-Avilés F, Rovira M, Martinez C, Salas MQ. Pinto FR, et al. Among authors: esteve j. Eur J Haematol. 2024 Dec 30. doi: 10.1111/ejh.14378. Online ahead of print. Eur J Haematol. 2024. PMID: 39739412
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.
Vives S, Quintela D, Morgades M, Cano-Ferri I, Serrano A, Acuña-Cruz E, Cervera M, Díaz-Beyá M, Vidriales B, Raposo-Puglia JÁ, Arnan M, Garrido A, Balerdi A, Cabello AI, Herrera-Puente P, Serrano J, Coll R, Tormo M, López-Marín J, García-Ávila S, Casado MS, Padilla I, Rodríguez-Macías G, Calbacho M, Puchol A, Hernández A, Torres M, Costilla L, Colorado MM, Martínez-Cuadrón D, Esteve J, Montesinos P; CETLAM and PETHEMA Groups. Vives S, et al. Among authors: esteve j. Cancers (Basel). 2024 Nov 30;16(23):4028. doi: 10.3390/cancers16234028. Cancers (Basel). 2024. PMID: 39682214 Free PMC article.
The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13).
Schmälter AK, Labopin M, Versluis J, Gallego Hernanz MP, Eder M, von dem Borne P, Socié G, Chevallier P, Forcade E, Neubauer A, Baron F, Bazarbachi A, Bug G, Nagler A, Schmid C, Esteve J, Mohty M, Ciceri F. Schmälter AK, et al. Among authors: esteve j. Am J Hematol. 2025 Jan;100(1):85-92. doi: 10.1002/ajh.27496. Epub 2024 Nov 18. Am J Hematol. 2025. PMID: 39558209 Free PMC article.
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy.
Gil-Lianes J, Mozas P, Baumann T, Combalia A, Baliu-Piqué C, García A, Rovira M, López-Guerra M, Villamor N, Colomer D, Rozman M, Esteve J, Estrach T. Gil-Lianes J, et al. Among authors: esteve j. Actas Dermosifiliogr. 2024 Nov 2:S0001-7310(24)00871-8. doi: 10.1016/j.ad.2024.11.002. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39491613 English, Spanish.
683 results